Published in Br J Pharmacol on August 20, 2007
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol (2009) 2.23
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Mol Pharmacol (2010) 1.86
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia (2010) 1.70
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br J Pharmacol (2007) 1.65
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A (2009) 1.63
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem (2009) 1.60
The endocannabinoid system and pain. CNS Neurol Disord Drug Targets (2009) 1.59
Novel cannabinoid receptors. Br J Pharmacol (2007) 1.55
Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization. Eur J Neurosci (2010) 1.50
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem (2010) 1.49
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J Cell Sci (2008) 1.48
GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol (2010) 1.39
Endocannabinoid signaling in microglial cells. Neuropharmacology (2008) 1.36
Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther (2010) 1.24
Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat (2009) 1.23
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. Br J Pharmacol (2010) 1.10
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis (2010) 1.07
Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J (2009) 1.07
N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels. Br J Pharmacol (2010) 1.04
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proc Natl Acad Sci U S A (2013) 1.00
Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol (2014) 0.98
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. Lab Invest (2011) 0.96
The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes (2011) 0.96
The therapeutic potential of novel cannabinoid receptors. Pharmacol Ther (2009) 0.95
Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. Curr Med Chem (2010) 0.95
Novel lysophosphoplipid receptors: their structure and function. J Lipid Res (2014) 0.94
Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction. J Pharmacol Exp Ther (2008) 0.94
Endocannabinoids and the heart. J Cardiovasc Pharmacol (2009) 0.94
Dynamic regulation of the endocannabinoid system: implications for analgesia. Mol Pain (2009) 0.93
N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. Br J Pharmacol (2010) 0.91
GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. PLoS One (2013) 0.90
A potential role for GPR55 in gastrointestinal functions. Curr Opin Pharmacol (2012) 0.90
A GPR18-based signalling system regulates IOP in murine eye. Br J Pharmacol (2013) 0.90
Effects of opioids, cannabinoids, and vanilloids on body temperature. Front Biosci (Schol Ed) (2011) 0.90
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. Br J Pharmacol (2008) 0.89
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction. Front Psychiatry (2013) 0.88
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology (2013) 0.86
GPR55 and the vascular receptors for cannabinoids. Br J Pharmacol (2007) 0.86
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling. Br J Pharmacol (2014) 0.85
Endocannabinoids and cardiac contractile function: pathophysiological implications. Pharmacol Res (2009) 0.84
The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure. J Pharmacol Exp Ther (2014) 0.84
In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints. Br J Pharmacol (2007) 0.84
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms. J Mol Med (Berl) (2012) 0.83
Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice. Pharmacology (2012) 0.83
Differential effects of lysophospholipids on exocytosis in rat PC12 cells. J Neural Transm (Vienna) (2010) 0.82
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins Other Lipid Mediat (2009) 0.81
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. J Biol Chem (2014) 0.81
Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. Pharmacol Res Perspect (2015) 0.80
New insights on endocannabinoid transmission in psychomotor disorders. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.79
Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat. Br J Pharmacol (2007) 0.79
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55. Chem Phys Lipids (2010) 0.79
GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses. PLoS One (2014) 0.78
The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells. Br J Pharmacol (2015) 0.78
The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Front Pharmacol (2015) 0.78
A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats. Br J Pharmacol (2010) 0.78
Role of GPR55 during Axon Growth and Target Innervation(1,2,3). eNeuro (2015) 0.77
Intercellular Lipid Mediators and GPCR Drug Discovery. Biomol Ther (Seoul) (2013) 0.77
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation. PLoS One (2013) 0.76
Endothelial atypical cannabinoid receptor: do we have enough evidence? Br J Pharmacol (2014) 0.76
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief. ISRN Anesthesiol (2011) 0.76
The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins. Cell Commun Signal (2011) 0.76
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol. Front Pharmacol (2017) 0.75
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment. J Inflamm (Lond) (2016) 0.75
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins. Life Sci (2014) 0.75
Lysophosphatidylinositol Signalling and Metabolic Diseases. Metabolites (2016) 0.75
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review. Mol Neurobiol (2016) 0.75
The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats. J Cardiovasc Pharmacol (2016) 0.75
Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 13.45
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 10.05
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev (2002) 8.50
Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet (1997) 3.85
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A (1999) 3.54
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol (1995) 2.95
Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today (1997) 2.49
Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension (1999) 2.03
Evidence for novel cannabinoid receptors. Pharmacol Ther (2005) 2.00
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol (2003) 1.95
In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci (2005) 1.77
The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol (2004) 1.56
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. Br J Pharmacol (2005) 1.05
Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. J Pharm Pharmacol (2004) 1.04
A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia (1977) 1.00
Cannabinoid receptor binding to membrane homogenates and cannabinoid-stimulated [35S]GTPgammaS binding to membrane homogenates or intact cultured cells. Methods Mol Med (2006) 0.90
Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res (1998) 106.16
Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res (1998) 96.63
Consed: a graphical tool for sequence finishing. Genome Res (1998) 59.36
MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics (1987) 54.39
Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci U S A (1987) 35.83
Global water resources: vulnerability from climate change and population growth. Science (2000) 16.61
Zebrafish informatics and the ZFIN database. Methods Cell Biol (1999) 16.45
Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med (1998) 15.09
A genetic linkage map of the human genome. Cell (1987) 13.37
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
Global threats to human water security and river biodiversity. Nature (2010) 11.84
Automated finishing with autofinish. Genome Res (2001) 7.97
Genes galore: a summary of methods for accessing results from large-scale partial sequencing of anonymous Arabidopsis cDNA clones. Plant Physiol (1994) 7.42
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol (1990) 6.73
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Analysis of expressed sequence tags indicates 35,000 human genes. Nat Genet (2000) 6.11
The C. elegans genome sequencing project: a beginning. Nature (1992) 5.36
Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol (1990) 5.20
Yeast-enhanced green fluorescent protein (yEGFP): a reporter of gene expression in Candida albicans. Microbiology (1997) 5.00
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
OSP: a computer program for choosing PCR and DNA sequencing primers. PCR Methods Appl (1991) 4.72
A survey of expressed genes in Caenorhabditis elegans. Nat Genet (1992) 4.63
Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol (1983) 4.52
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
Molecular evidence for genetic mixing of Arctic and Antarctic subpolar populations of planktonic foraminifers. Nature (2000) 3.58
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A (1996) 3.50
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J (2001) 3.48
CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast (2000) 3.34
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 3.32
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A (1999) 3.32
Enzyme null alleles in natural populations of Drosophila melanogaster: Frequencies in a North Carolina population. Proc Natl Acad Sci U S A (1980) 3.24
Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol (1994) 3.23
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature (1999) 3.20
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
The contribution of HLA to rheumatoid arthritis. Clin Genet (1989) 2.94
Genetic linkage map of human chromosome 7 with 63 DNA markers. Proc Natl Acad Sci U S A (1987) 2.91
Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology (2000) 2.86
Non-Hodgkin's lymphoma presenting as polyarthritis. Br J Rheumatol (1994) 2.77
Gate-tuning of graphene plasmons revealed by infrared nano-imaging. Nature (2012) 2.75
The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol (1996) 2.68
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism (1996) 2.60
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science (1998) 2.46
The generation and utilization of energy during growth. Adv Microb Physiol (1971) 2.44
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
A questionnaire for patients' evaluations of their physicians' humanistic behaviors. J Gen Intern Med (1993) 2.41
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
An evaluation of the Health Assessment Questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol (1993) 2.27
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun (1997) 2.24
Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol (2001) 2.18
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
Detecting patterns in protein sequences. J Mol Biol (1994) 2.16
Musculoskeletal examination for medical students: the need to agree what we teach. Rheumatology (Oxford) (2002) 2.16
Null allele frequencies at allozyme loci in natural populations of Drosophila melanogaster. Genetics (1981) 2.14
Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection. J Virol (2000) 2.11
World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestation on dogs and cats. Vet Parasitol (2006) 2.09
Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int (1998) 2.07
Increased cerebrospinal-fluid pressure during treatment of diabetic ketosis. Lancet (1971) 2.07
A laccase associated with lignification in loblolly pine xylem. Science (1993) 2.06
Multipoint linkage analysis in neurofibromatosis type I: an international collaboration. Am J Hum Genet (1989) 2.04
Case report: foreign body in the palate of an infant. Br Dent J (2008) 2.04
The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem (1998) 2.03
A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc Natl Acad Sci U S A (1994) 1.99
A patient-centred approach to drug regulation. Rheumatology (Oxford) (2006) 1.98
Interaction of cAMP receptor protein with the ompA gene, a gene for a major outer membrane protein of Escherichia coli. FEBS Lett (1981) 1.94
Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care (2001) 1.93
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Oligonucleotide probe for detection and identification of Campylobacter pylori. J Clin Microbiol (1989) 1.90
The meningococcal carrier-rate. Lancet (1973) 1.89
Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci (2004) 1.89
Insertion-deletion variation at the yellow-achaete-scute region in two natural populations of Drosophila melanogaster. Genet Res (1989) 1.87
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int (2006) 1.84
Antiviral antibodies in rheumatoid arthritis discordant HLA-identical same-sexed sibling pairs. Br J Rheumatol (1992) 1.81
Idiopathic mouth ulcers in sheep, cattle and horses. Vet Rec (2001) 1.80
The relationship between mRNA stability and length in Saccharomyces cerevisiae. Nucleic Acids Res (1986) 1.73
Conservation in rat liver of light and heavy subunit sequences of mammalian ferritin. Presence of unique octopeptide in the light subunit. J Biol Chem (1984) 1.73
The efficiency of folding of some proteins is increased by controlled rates of translation in vivo. A hypothesis. J Mol Biol (1987) 1.72
Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr (1995) 1.72
Temperature dependence of the Raman spectra of graphene and graphene multilayers. Nano Lett (2007) 1.71
Sequence-tagged site (STS) content mapping of human chromosomes: theoretical considerations and early experiences. PCR Methods Appl (1991) 1.70
Identification of candidate coding region single nucleotide polymorphisms in 165 human genes using assembled expressed sequence tags. Genome Res (1999) 1.70
Criminalisation of HIV transmission: implications for public health in Scotland. BMJ (2001) 1.69
CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci U S A (1997) 1.69
Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J (2010) 1.69
Scan of human genome reveals no new Loci under ancient balancing selection. Genetics (2006) 1.68
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J Infect Dis (2001) 1.67
Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation (1995) 1.66
Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS (1992) 1.65
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine. J Infect Dis (2000) 1.64
Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet (1991) 1.63
Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest (1996) 1.63
Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock. Am J Physiol Lung Cell Mol Physiol (2010) 1.63
p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int (2001) 1.63
Thermosensitive H1 plasmids determining citrate utilization. J Gen Microbiol (1978) 1.62